Tools / Trials and research SLC12A3: Solute carrier family 12 member 3 A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Electroneutral sodium and chloride ion cotransporter, which acts as a key mediator of sodium and chloride reabsorption in kidney distal convoluted tubules.
Drugs that act on it : 13 Approved : 13 In phases 1 to 3 : 0 Sponsors : 10 Type : Protein Who Is On It, and How Far Along Every drug ChEMBL records acting on SLC12A3, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved13 Hydrochlorothiazide Hydrochlorothiazide SponsorNovartis Pharmaceuticals ModalitySmall molecule ActionInhibitor Open trials25 Chlorothiazide Chlorothiazide SponsorDaiichi Sankyo ModalitySmall molecule ActionInhibitor Open trials16 Indapamide Indapamide SponsorSanofi ModalitySmall molecule ActionInhibitor Open trials13 Chlorthalidone Chlorthalidone SponsorSanofi ModalitySmall molecule ActionInhibitor Open trials11 Metolazone Metolazone SponsorI3 Pharms ModalitySmall molecule ActionInhibitor Open trials6 Bendroflumethiazide Bendroflumethiazide SponsorBristol-Myers Squibb ModalitySmall molecule ActionInhibitor Open trials2 Benzthiazide Benzthiazide SponsorPfizer ModalitySmall molecule ActionInhibitor Open trials1 Cyclothiazide Cyclothiazide SponsorEli Lilly ModalitySmall molecule ActionInhibitor Open trials0 Hydroflumethiazide Hydroflumethiazide SponsorTakeda Pharmaceuticals USA ModalitySmall molecule ActionInhibitor Open trials0 Methyclothiazide Methyclothiazide SponsorAbbVie ModalitySmall molecule ActionInhibitor Open trials0 Polythiazide Polythiazide SponsorPfizer ModalitySmall molecule ActionInhibitor Open trials0 Quinethazone Quinethazone SponsorPfizer ModalitySmall molecule ActionInhibitor Open trials0 Trichlormethiazide Trichlormethiazide SponsorMerck & Co. (MSD) ModalitySmall molecule ActionInhibitor Open trials0
Modalities Modalities Share Copy link Download image (PNG)Drugs on this target by ChEMBL molecule type.
Small molecule 13 100%Small molecule Count13 Share100%
The Landscape Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Thiazide-sensitive sodium-chloride cotransporter inhibitor.
Open Trials The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 35 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension Chlorthalidone — Recruiting HK inno.N Corporation 2026-11-12 Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension Hydrochlorothiazide Phase 4 Not yet recruiting China National Center for Cardiovascular Diseases 2026-11-12 Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension Chlorthalidone — Recruiting Hanmi Pharmaceutical Company Limited 2026-08-25 Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS) Indapamide Phase 2 Not yet recruiting Eva M.M. Strijbis 2026-08-14 SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy Hydrochlorothiazide, Chlorothiazide Phase 4 Not yet recruiting Ottawa Hospital Research Institute 2026-07-07 Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention Hydrochlorothiazide Not applicable Recruiting National Medical Research Center for Therapy and Preventive Medicine 2026-07-06 Polypills Approach for Multiple Cardiovascular Risk Factors Indapamide Not applicable Recruiting China Medical University, China 2026-07-01 LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial Chlorthalidone Phase 2 Not yet recruiting VA Office of Research and Development 2026-06-12 Vertebrobasilar Dolichoectasia Treatment With Amiloride Hydrochlorothiazide Phase 2 Not yet recruiting Huashan Hospital 2026-06-08 TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart Failure Hydrochlorothiazide, Chlorothiazide Phase 4 Not yet recruiting Lucrecia Maria Burgos 2026-05-18 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Chlorothiazide Not applicable Enrolling by invitation Enhanced Emirates Limited 2026-05-06 POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Hydrochlorothiazide, Chlorothiazide Phase 2 / Phase 3 Not yet recruiting Hospital de Clinicas de Porto Alegre 2026-03-13 Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control Hydrochlorothiazide, Chlorothiazide Not applicable Recruiting The University of Hong Kong 2026-03-09 PrP-targeting siRNA Safety & Mechanism Study Benzthiazide Phase 1 Recruiting Broad Institute of MIT and Harvard 2026-03-03 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions Indapamide Phase 1 Not yet recruiting Boryung Pharmaceutical Co., Ltd 2026-02-19 Add-on Diuretics in Acute Decompensated Heart Failure Metolazone Phase 2 Recruiting Tanta University 2026-01-28 Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients Hydrochlorothiazide, Chlorothiazide Phase 4 Recruiting Chinese University of Hong Kong 2025-12-09 Rapid Management of Resistant Hypertension in the Public Health System (Fast Control) Indapamide Not applicable Recruiting Instituto Dante Pazzanese de Cardiologia 2025-12-02 Antihypertensive Drug Selection Based on Hemodynamic Phenotypes Indapamide Phase 4 Not yet recruiting The Third Xiangya Hospital of Central South University 2025-11-21 Cardiac Effects of Mineralocorticoid Receptor Antagonism After Hypertensive Disorders of Pregnancy Chlorthalidone Phase 2 Recruiting Massachusetts General Hospital 2025-11-20 Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension Indapamide Phase 3 Not yet recruiting Yan Li 2025-11-18 CaOx Stone Prevention Chlorthalidone Phase 4 Recruiting Icahn School of Medicine at Mount Sinai 2025-11-10 Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure Metolazone Not applicable Recruiting University of Health Sciences Lahore 2025-09-30 Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Indapamide Phase 2 Enrolling by invitation Shin Poong Pharmaceutical Co. Ltd. 2025-07-14 Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism Indapamide Phase 4 Recruiting Lars Rejnmark 2025-06-24 The Role of Skin Sodium Accumulation in Chronic Kidney Disease Chlorothiazide Not applicable Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2025-06-13 Arterial Stiffness and Blood Pressure Chlorthalidone Not applicable Recruiting VA Office of Research and Development 2024-07-11 Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension Chlorthalidone — Active, not recruiting Yuhan Corporation 2024-02-28 Acetazolamide or Metolazone in Acute Heart Failure Metolazone Not applicable Not yet recruiting Clinica Alemana de Santiago 2024-02-22 Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts Metolazone Phase 4 Recruiting Heart Center Research, LLC 2024-01-23 Mechanisms of Diuretic Resistance in Heart Failure, Aim 3 Bendroflumethiazide Phase 1 Recruiting Yale University 2024-01-17 Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload Metolazone Phase 3 Recruiting Johannes Grand 2023-12-12 Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention Chlorthalidone, Chlorothiazide Phase 2 Recruiting Insel Gruppe AG, University Hospital Bern 2023-11-01 Mechanisms of Diuretic Resistance in Heart Failure, Aim 2 Bendroflumethiazide Phase 1 Recruiting Yale University 2023-03-03 Ertugliflozin in Chronic Heart Failure Metolazone Phase 2 Recruiting Yale University 2020-06-18
Show all 35Diseases Most Associated With It Open Targets association score, 0 to 1; all associations
Gitelman syndrome 0.85
Hypertensive disorder 0.66
Congestive heart failure 0.61
Cardiovascular disorder 0.59
Preeclampsia 0.57
Stroke disorder 0.55 Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1876 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-18. Gene name, function (UniProt P55017 , CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets